All News about Gilead Sciences
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
What 8 Analyst Ratings Have To Say About Gilead Sciences
June 14, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240614729632/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_4.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
June 13, 2024
Via Benzinga
![](https://g.foolcdn.com/editorial/images/779938/retired-woman-investing-laptop-401k-ira.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240606954431/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://g.foolcdn.com/editorial/images/775835/gettyimages-643757808-1200x815-55a7da8.jpg)
![](https://investorplace.com/wp-content/uploads/2024/01/growthstocks1600.png)
![](https://investorplace.com/wp-content/uploads/2024/01/growthstocks1600.png)
![](https://mms.businesswire.com/media/20240604334684/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/04/HIV-AIDS-via-shutterstock.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2024/04/dividend-stocks1600-4.png)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Large Cap BIopharmaceuticals Overview
June 03, 2024
Via Talk Markets
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2024/06/03/RCUS.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240603095365/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240603718191/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240531380992/en/2147242/5/ARCUS_Logo_RGB_1920x1080.jpg)
![](https://mms.businesswire.com/media/20240531335673/en/2147237/5/ARCUS_Logo_RGB_1920x1080.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/31/Gilead.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240530725767/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240530516266/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Provides Update on Phase 3 TROPiCS-04 Study
May 30, 2024
Via Business Wire
Is Nvidia Worth 35x Times Sales, History Says No
May 29, 2024
Via Talk Markets
Exposures
US Equities
![](https://g.foolcdn.com/editorial/images/778181/physician-talking-to-patient.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://mms.businesswire.com/media/20240522704668/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.